For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, LifeMD Inc (NASDAQ: LFMD) closed at $12.45 down -2.12% from its previous closing price of $12.72. In other words, the price has decreased by -$2.12 from its previous closing price. On the day, 2.49 million shares were traded. LFMD stock price reached its highest trading level at $12.7284 during the session, while it also had its lowest trading level at $11.93.
Ratios:
For a deeper understanding of LifeMD Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.59. For the most recent quarter (mrq), Quick Ratio is recorded 0.77 and its Current Ratio is at 0.82.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on December 10, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 02 ’25 when Schreiber Justin sold 25,000 shares for $12.47 per share. The transaction valued at 311,655 led to the insider holds 2,525,721 shares of the business.
Schreiber Justin sold 21,995 shares of LFMD for $165,684 on May 01 ’25. The Chairman and CEO now owns 2,553,726 shares after completing the transaction at $7.53 per share. On May 02 ’25, another insider, Schreiber Justin, who serves as the Chairman and CEO of the company, sold 3,005 shares for $7.50 each. As a result, the insider received 22,539 and left with 2,550,721 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 578093312 and an Enterprise Value of 558464128. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.42. Its current Enterprise Value per Revenue stands at 2.387 whereas that against EBITDA is -95.221.
Stock Price History:
The Beta on a monthly basis for LFMD is 2.43, which has changed by 0.5859872 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $13.25, while it has fallen to a 52-week low of $3.99. The 50-Day Moving Average of the stock is 52.78%, while the 200-Day Moving Average is calculated to be 104.65%.
Shares Statistics:
For the past three months, LFMD has traded an average of 1.78M shares per day and 1762540 over the past ten days. A total of 43.53M shares are outstanding, with a floating share count of 36.15M. Insiders hold about 20.45% of the company’s shares, while institutions hold 36.40% stake in the company. Shares short for LFMD as of 1747267200 were 3864706 with a Short Ratio of 2.17, compared to 1744675200 on 6170664. Therefore, it implies a Short% of Shares Outstanding of 3864706 and a Short% of Float of 10.299999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.16, with high estimates of $0.16 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.64 and $0.0 for the fiscal current year, implying an average EPS of $0.32. EPS for the following year is $0.6, with 2.0 analysts recommending between $0.95 and $0.25.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $66.3M this quarter.It ranges from a high estimate of $67.71M to a low estimate of $65.3M. As of the current estimate, LifeMD Inc’s year-ago sales were $50.66MFor the next quarter, 8 analysts are estimating revenue of $67.76M. There is a high estimate of $68.69M for the next quarter, whereas the lowest estimate is $67M.
A total of 8 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $273.23M, while the lowest revenue estimate was $266.8M, resulting in an average revenue estimate of $270.32M. In the same quarter a year ago, actual revenue was $212.45MBased on 7 analysts’ estimates, the company’s revenue will be $318.23M in the next fiscal year. The high estimate is $355M and the low estimate is $297.5M.
